ICA Group Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-159
Closed -$82.4K 919
2024
Q1
$82.4K Hold
159
0.02% 449
2023
Q4
$75K Buy
+159
New +$73.5K 0.02% 428
2023
Q3
Sell
-148
Closed -$65.8K 485
2023
Q2
$65.8K Buy
148
+142
+2,367% +$65.5K 0.02% 429
2023
Q1
$2.76K Hold
6
﹤0.01% 1039
2022
Q4
$3.08K Buy
+6
New +$3.05K ﹤0.01% 1053

Other funds holding ELV

ICA Group Wealth Management's ELV Position: Q2 2024 in Review

ICA Group Wealth Management sold out of Elevance Health (ELV) in Q2 2024, closing a stake of 159 shares — an estimated $82.4K sold.

ICA Group Wealth Management first reported a position in ELV in Q4 2022 and held it in 5 quarters. The position peaked at $82.4K in Q1 2024. 1,705 funds tracked by Wall St. Rank hold ELV as of Q2 2024.

  • ICA Group Wealth Management reported no remaining Elevance Health position as of Q2 2024 after selling out during the quarter.
  • ICA Group Wealth Management sold 159 Elevance Health shares in Q2 2024, an estimated $82.4K.
  • ICA Group Wealth Management first reported a position in Elevance Health in Q4 2022 and held it in 5 quarters.
  • ICA Group Wealth Management's Elevance Health position peaked at $82.4K in Q1 2024.
  • 1,705 funds tracked by Wall St. Rank held Elevance Health as of Q2 2024.

Based on ICA Group Wealth Management's 13F filing for Q2 2024, filed 8 Aug 2024.